Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood.
Aalbers AM, van den Heuvel-Eibrink MM, de Haas V, Te Marvelde JG, de Jong AX, van der Burg M, Dworzak M, Hasle H, Locatelli F, De Moerloose B, Schmugge M, Stary J, Zecca M, Zwaan CM, van de Loosdrecht AA, van Dongen JJ, Niemeyer CM, van der Velden VH. Aalbers AM, et al. Among authors: hasle h. Leukemia. 2013 Sep;27(9):1923-5. doi: 10.1038/leu.2013.81. Epub 2013 Mar 15. Leukemia. 2013. PMID: 23493026 No abstract available.
The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML).
Hasle H, Baumann I, Bergsträsser E, Fenu S, Fischer A, Kardos G, Kerndrup G, Locatelli F, Rogge T, Schultz KR, Starý J, Trebo M, van den Heuvel-Eibrink MM, Harbott J, Nöllke P, Niemeyer CM; European Working Group on childhood MDS. Hasle H, et al. Leukemia. 2004 Dec;18(12):2008-14. doi: 10.1038/sj.leu.2403489. Leukemia. 2004. PMID: 15496981
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS.
Aalbers AM, van der Velden VH, Yoshimi A, Fischer A, Noellke P, Zwaan CM, Baumann I, Beverloo HB, Dworzak M, Hasle H, Locatelli F, De Moerloose B, Göhring G, Schmugge M, Stary J, Zecca M, Langerak AW, van Dongen JJ, Pieters R, Niemeyer CM, van den Heuvel-Eibrink MM. Aalbers AM, et al. Among authors: hasle h. Leukemia. 2014 Jan;28(1):189-92. doi: 10.1038/leu.2013.195. Epub 2013 Jun 28. Leukemia. 2014. PMID: 23807769 No abstract available.
T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS.
Aalbers AM, van den Heuvel-Eibrink MM, Baumann I, Beverloo HB, Driessen GJ, Dworzak M, Fischer A, Göhring G, Hasle H, Locatelli F, De Moerloose B, Noellke P, Schmugge M, Stary J, Yoshimi A, Zecca M, Zwaan CM, van Dongen JJ, Pieters R, Niemeyer CM, van der Velden VH, Langerak AW. Aalbers AM, et al. Among authors: hasle h. Blood Cancer J. 2014 May 2;4(5):e209. doi: 10.1038/bcj.2014.28. Blood Cancer J. 2014. PMID: 24786393 Free PMC article.
JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia.
Zecca M, Bergamaschi G, Kratz C, Bergsträsser E, Danesino C, De Filippi P, Hasle H, Lisini D, Locatelli F, Pession A, Sainati L, Starý J, Trebo M, van den Heuvel-Eibrink M, Wójcik D, Niemeyer CM. Zecca M, et al. Among authors: hasle h. Leukemia. 2007 Feb;21(2):367-9. doi: 10.1038/sj.leu.2404484. Epub 2006 Dec 7. Leukemia. 2007. PMID: 17151700 No abstract available.
Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia.
Kratz CP, Niemeyer CM, Thomas C, Bauhuber S, Matejas V, Bergsträsser E, Flotho C, Flores NJ, Haas O, Hasle H, van den Heuvel-Eibrink MM, Kucherlapati RS, Lang P, Roberts AE, Starý J, Strahm B, Swanson KD, Trebo M, Zecca M, Neel B, Locatelli F, Loh ML, Zenker M. Kratz CP, et al. Among authors: hasle h. Leukemia. 2007 May;21(5):1108-9. doi: 10.1038/sj.leu.2404620. Epub 2007 Feb 22. Leukemia. 2007. PMID: 17315019 No abstract available.
Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.
Yoshimi A, Mohamed M, Bierings M, Urban C, Korthof E, Zecca M, Sykora KW, Duffner U, Trebo M, Matthes-Martin S, Sedlacek P, Klingebiel T, Lang P, Führer M, Claviez A, Wössmann W, Pession A, Arvidson J, O'Marcaigh AS, van den Heuvel-Eibrink MM, Starý J, Hasle H, Nöllke P, Locatelli F, Niemeyer CM. Yoshimi A, et al. Among authors: hasle h. Leukemia. 2007 Mar;21(3):556-60. doi: 10.1038/sj.leu.2404537. Epub 2007 Feb 1. Leukemia. 2007. PMID: 17268527 Clinical Trial. No abstract available.
A novel somatic K-Ras mutation in juvenile myelomonocytic leukemia.
Reimann C, Arola M, Bierings M, Karow A, van den Heuvel-Eibrink MM, Hasle H, Niemeyer CM, Kratz CP. Reimann C, et al. Among authors: hasle h. Leukemia. 2006 Sep;20(9):1637-8. doi: 10.1038/sj.leu.2404303. Epub 2006 Jul 6. Leukemia. 2006. PMID: 16826224 No abstract available.
370 results